Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Medication can effectively reduce hair growth and improve life quality for women with hirsutism.

Hirsutism in females is complex, often linked to tumors, and requires more research for better treatment.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

Finasteride safely reduces excessive hair growth in women.

Ovarian hyperthecosis caused high testosterone and virilization symptoms in a 60-year-old woman, which improved after surgery.

A postmenopausal woman had high testosterone from her right adrenal gland, leading to recommended surgery.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Treat hirsutism in premenopausal women with oral contraceptives and consider additional treatments if needed.

Finasteride reduces hair growth and is safe for women with excessive hair.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Finasteride effectively reduces excess hair in women with certain conditions.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

Women also use 5α-reductase inhibitors for hair loss and hirsutism.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.